Acute lymphoblastic leukaemia trials in Hong Kong

6 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 2/3Taking people
  Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol

  Where

  Hong Kong

  Age

  1 month to 18 years

  People

  1,800 worldwide

  Run by

  Institute of Hematology & Blood Diseases Hospital, China

  See details and how to joinNCT06764238
• Phase 2Not yet taking people in Hong Kong
  Asciminib & Standard-of-Care Integration in Maintenance Therapy for POST Allogeneic Stem Cell Transplant (Allo-HSCT) of Patient With Ph+ B-ALL or Blastic Transformed CML

  Where

  Hong Kong

  Age

  18 years and over

  People

  45

  Run by

  The University of Hong Kong

  See details and how to joinNCT07493408
• Phase 3Taking people
  Newly-diagnosed Pediatric Ph-positive B-ALL Protocol

  Where

  Hong Kong

  Age

  1 month to 18 years

  People

  150 worldwide

  Run by

  Institute of Hematology & Blood Diseases Hospital, China

  See details and how to joinNCT07152041
• Phase 2/3Taking people
  Newly-diagnosed Pediatric T-cell ALL Protocol

  Where

  Hong Kong

  Age

  1 month to 18 years

  People

  610 worldwide

  Run by

  Institute of Hematology & Blood Diseases Hospital, China

  See details and how to joinNCT06855810
• Phase 2/3Taking people
  Newly-diagnosed Low Risk Pediatric B-cell ALL Protocol

  Where

  Hong Kong

  Age

  1 year to 18 years

  People

  3,000 worldwide

  Run by

  Institute of Hematology & Blood Diseases Hospital, China

  See details and how to joinNCT06882057
• No phaseTaking people
  CD-19 CAR-T Cell for Pediatric ALL or Lymphoma

  Where

  Hong Kong

  Age

  1 year to 17 years

  People

  18

  Run by

  Hong Kong Children's Hospital

  See details and how to joinNCT06866873